Results 231 to 240 of about 414,488 (301)
Abstract Aims In the context of pharmacology and toxicology education, there is a growing shift toward programmatic assessment models that prioritize longitudinal learning, reflection and development of higher‐order cognitive skills. As part of this transition, we are exploring alternative and more meaningful forms of assessment. This qualitative study
Narin Akrawi +2 more
wiley +1 more source
Power, interests, and maternal health care: a political economy analysis of service delivery redesign in Kenya. [PDF]
Nzinga J +8 more
europepmc +1 more source
Cost–benefit analysis of screening programme for diabetic retinopathy in Bulgaria
Aims Late‐diagnosed diabetic retinopathy (DR) is difficult and expensive to treat. Screening programmes can identify the disease early and reduce the costs of its future treatment. This study aims to analyse the cost–benefit of screening programmes for DR.
Iva Nenkova +5 more
wiley +1 more source
Feedback is the most powerful driver of learning, but it can afford variable effects depending on the method used. The design of feedback for computer‐based assessment—now increasingly prevalent in higher education—remains relatively underexplored, particularly for pharmacology education.
Claire Y. Hepburn
wiley +1 more source
Barriers and opportunities in implementing adolescent sexual and reproductive health interventions in rural Guatemala: an exploratory descriptive study. [PDF]
Chaparro Buitrago DC +4 more
europepmc +1 more source
Aims The aim of this study was to introduce a new assessment method for pharmacy students' real‐life competence in reviewing medications after obligatory advanced‐level practical internship in Finland. Methods The new medication review (MR) competence assessment method consisted of (1) a self‐assessment by pharmacy students and (2) a performance ...
Katja Leiman +5 more
wiley +1 more source
Strengthening health technology assessment in Greece: industry-identified barriers and recommendations. [PDF]
George P, Eleftheria K, Kostas A.
europepmc +1 more source
Patient‐reported outcomes (PROs) are essential for assessing clinical benefit and tolerability from the patient's perspective. In oncology trials, PRO data analysis often involves responder and time‐to‐event analyses, which depend on predefined thresholds to determine clinically meaningful change.
Anna Margarete Maria Thurner +5 more
wiley +1 more source
Applying participatory systems approaches to enhance child mental health in local communities in Denmark: a process evaluation. [PDF]
Ryom K +8 more
europepmc +1 more source
The Nottinghamshire Neurodiversity Network: building a multidisciplinary team of experts to improve pathways to care. [PDF]
French B, Groom M.
europepmc +1 more source

